Protalix BioTherapeutics
PLX
#8930
Rank
โ‚น15.70 B
Marketcap
โ‚น194.95
Share price
4.06%
Change (1 day)
44.91%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.90. In 2024 the company made an earnings per share (EPS) of โ‚น3.80 a decrease over its 2023 EPS that were of โ‚น11.41.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-54.13%
2024โ‚น3.80-66.67%
2023โ‚น11.41-138.71%
2022-โ‚น29.48-50%
2021-โ‚น58.96181.82%
2020-โ‚น20.92-82.11%
2019-โ‚น116.97-31.67%
2018-โ‚น171.18-72.31%
2017-โ‚น618.15124.14%
2016-โ‚น275.79-147.54%
2015โ‚น580.11-290.63%
2014-โ‚น304.326.67%
2013-โ‚น285.30130.77%
2012-โ‚น123.63-69.77%
2011-โ‚น408.9319.44%
2010-โ‚น342.36-12.2%
2009-โ‚น389.9136.67%
2008-โ‚น285.30-37.5%
2007-โ‚น456.4850%
2006-โ‚น304.323.23%
2005-โ‚น294.81138.46%
2004-โ‚น123.63-74%
2003-โ‚น475.50-0%
2002-โ‚น475.50-50%
2001-โ‚น951.00233.33%
2000-โ‚น285.30-84.21%
1999-โ‚น1,807-24%
1998-โ‚น2,377-600%
1997โ‚น475.50-16.67%
1996โ‚น570.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น124.58 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น638.12 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.46-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น130.29 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel